Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis

Acta Neurochirurgica

Volumn 141, Issue 5, 1999, Pages 481-486

  Mizoue, T ^a,b   Kawamoto, H ^a   Arita, K ^a   Tominaga, A ^a   Kurisu, K ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

Author keywords

Cell immunoblot; Matrix metalloproteinase 9; Meningioma; Tissue inhibitor of metalloproteinase 1

Indexed keywords

ANTIBODY; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; DURA MATER; ENZYME ACTIVITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; MENINGIOMA; PRIORITY JOURNAL;

ADULT; AGED; COLLAGENASES; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MENINGEAL NEOPLASMS; MENINGIOMA; METALLOENDOPEPTIDASES; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0032969155     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050328     Document Type: Article

References (21)

1. 1. Arita J, Kojima Y, Kimura F (1993) Measurement of the secretion of a small peptide at he single cell level by the cell immunoblot assay: thyroidectomy increases the number of substance P-secreting anterior pituitary cells. Endocrinology 132: 2682-2688
2. 2. Ballin M, Goweg D, Sinha C, Thorgeirsson U (1988) Ras oncogene mediated induction of a 92 kDa metalloproteinase: strong correlation with the malignant phenotype. Biochem Biophys Res Commun 154: 832-838
3. 3. Graham C, Connelly I, MacDougall J, Kerbel R, Stetler-Stevenson W, Lala P (1994) Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-ß. Exp Cell Res 214: 93-99
4. 4. Halaka AN, Bunning RA, Bird CC, Gibson M, Reynolds JJ (1983) Production of collagenase and inhibitor (TIMP) by intracranial tumours and dura in vitro. J Neurosurg 59: 461-466
5. 5. Kawamoto K, Uozumi T, Arita K, Takechi A, Kawamoto H (1995) Secretion of growth hormone (GH)-releasing hormone by GH-producing pituitary adenoma assessed by cell immunoblot analysis. Endocrine J 42: 89-93
6. 6. Kawamoto H, Uozumi T, Kawamoto K, Arita K, Yano T, Hirohata T (1996) Type IV collagenase activity and cavernous sinus invasion in human pituitay adenomas. Acta Neurochir (Wien) 138: 390-395
7. 7. Kawamoto H, Kawamoto K, Mizoue T, Uozumi T, Arita K, Kurisu K (1996) Matrix melalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis. Acta Neurochir (Wien) 138: 1442-1448
8. 8. Liotta L, Sletler-Stevenson W (1990) Metalloproteinases and cancer invasion. Cancer Biol 1: 99-106
9. 9. Mackay A, Ballin M, Pelina M, Farina A, Nason A, Hartzler J, Thorgeisson U (1992) Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumour and normal cell lines. Invasion Metastasis 12: 168-184
10. 10. Moll U, Youngleib G, Rosinski K, Quigley J (1990) Tumour promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells. Isolation and characterization of the enzyme from HT1080 tumour cells. Cancer Res 50: 6162-6170
11. 11. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y (1994) Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumours. J Neurosurg 81: 69-77
12. 12. Nakagawa T, Kubota T, Kabuto M, Kodera T (1995) Captopril inhibits glioma cell invasion in vitro: involvement of matrix metalloproteinases. Anticancer Res 15: 1985-1989
13. 13. Nakagawa T, Kubota T, Kabuto M, Sato K, Arai Y, Kodera T (1995) Production of tissue inhibitor of metalloproteinases-1 (TIMP-1) by human astrocytic tumours. Neurol Med Chir Tokyo 35: 728-731
14. 14. Nakajima M, Welch D, Wynn D, Tsuruo T, Nicolson G (1993) Serum and plasma Mr 92,000 progelatinase levels correlate with spontaneous metastases of rat 13762 NF mammary adenocarinoma. Cancer Res 53: 5802-5807
15. 15. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J (1995) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298-307
16. 16. Rao J, Steck P, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson W, Liotta L, Sawaya R (1994) Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neurooncol 18: 129-138
17. 17. Stetler-Stevenson W (1990) Type IV collagenase in tumour invasion and metastasis. Cancer Metastasis Rev 9: 289-308
18. 18. Stetler-Stevenson W, Liotta L, Kleiner D (1993) Extracellular matrix 6: Role of matrix metalloproteinases in tumour invasion and metastasis. FASEB J 7: 1434-1441
19. 19. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y (1993) Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 104: 991-999
20. 20. Woessner J (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154
21. 21. Yamagata S, Ito Y, Tanaka R, Shimazu S (1988) Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate gel electrophoresis. Biochem Biophys Res Commun 151: 158-162